Application of secondary ion mass spectrometry to the determination of Mg/Ca in rare, delicate, or altered planktonic foraminifera : examples from the Holocene, Paleogene, and Cretaceous

Author Posting. © American Geophysical Union, 2005. This article is posted here by permission of American Geophysical Union for personal use, not for redistribution. The definitive version was published in Geochemistry Geophysics Geosystems 6 (2005): Q12P07, doi:10.1029/2005GC000974.Secondary ion mass spectrometry (SIMS) is useful for measuring Mg/Ca in both primary calcite and diagenetic minerals in planktonic foraminifera. The excellent spatial resolution (<10 μm) and small amount of material removed (<2 ng) makes it easy to avoid targets that include obvious embedding material and encrusting or infilling minerals such as secondary calcite and authigenic clays in diagenetically altered samples. Because analyses can be performed on individuals, SIMS is also a viable technique for generating Mg/Ca values from sediment samples in which foraminifera are rare or have low mass. For clean primary calcite samples, Mg/Ca ratios from SIMS compare well to those obtained using inductively coupled plasma mass spectrometry (ICP-MS), while maintaining information regarding the true variability of elemental ratios within individual tests. For samples with secondary calcite or stubbornly adhering clays, SIMS enables us to accurately measure primary calcite compositions and to assess and reconcile contamination problems in bulk samples analyzed by solution-based ICP-MS. We have observed that SIMS is an invaluable and reliable tool for the identification and avoidance of problems of diagenesis and the analysis of rare or delicate planktonic foraminifera. However, because of operator time required to properly target delicate (thin-walled) or contaminated planktonic foraminifera, SIMS may not be feasible for Mg/Ca studies where large numbers (hundreds) of samples must be processed and bulk measurements on multiple individuals will suffice.Funding for this research was provided by The Andrew W. Mellon Foundation Endowed Fund for Innovative Research and by the U.S. Science Support Program of the Joint Oceanographic Institutions. This material is also based on work supported by the National Science Foundation under grant OCE-0334598. Partial support for the Northeast National Ion Microprobe Facility was provided by NSF (EAR-0115433). This research used samples and data provided by the Ocean Drilling Program (ODP). ODP is sponsored by the U.S. National Science Foundation and participating countries under management of Joint Oceanographic Institutions, Inc

Omega-3 fatty acids in parenteral nutrition: a systematic review with network meta-analysis on clinical outcomes

Background &amp; aims: Accumulating scientific evidence supports the benefits of parenteral nutrition (PN) with fish oil (FO) containing intravenous lipid emulsions (ILEs) on clinical outcomes. Yet, the question of the most effective ILE remains controversial. We conducted a network meta-analysis (NMA) to compare and rank different types of ILEs in terms of their effects on infections, sepsis, ICU and hospital length of stay, and in-hospital mortality in adult patients.Methods: MEDLINE, EMBASE, and Web of Science databases were searched for randomized controlled trials (RCTs) published up to May 2022, investigating ILEs as a part of part of PN covering at least 70% of total energy provision. Lipid emulsions were classified in four categories: FO-ILEs, olive oil (OO)-ILEs, medium-chain triglyceride (MCT)/soybean oil (SO)-ILEs, and pure SO-ILEs. Data were statistically com-bined through Bayesian NMA and the Surface Under the Cumulative RAnking (SUCRA) was calculated for all outcomes. Results: 1651 publications were retrieved in the original search, 47 RCTs were included in the NMA. For FO-ILEs, very highly credible reductions in infection risk versus SO-ILEs [odds ratio (OR) = 0.43 90% credibility interval (CrI) (0.29-0.63)], MCT/soybean oil-ILEs [0.59 (0.43-0.82)], and OO-ILEs [0.56 (0.33-0.91)], and in sepsis risk versus SO-ILEs [0.22 (0.08-0.59)], as well as substantial reductions in hospital length of stay versus SO-ILEs [mean difference (MD) =-2.31 (-3.14 to-1.59) days] and MCT/SO-ILEs (-2.01 (-2.82 to-1.22 days) were shown. According to SUCRA score, FO-ILEs were ranked first for all five outcomes.Conclusions: In hospitalized patients, FO-ILEs provide significant clinical benefits over all other types of ILEs, ranking first for all outcomes investigated. Registration no: PROSPERO 2022 CRD42022328660.(c) 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

Fiber-induced crystallization in elongational flows

Morphology development at the fiber/matrix interphase in fiber-reinforced isotactic polypropylene composites is a widely studied topic. While the application of shear flow may strongly enhance the nucleation density around the fiber, little is known about the influence of fibers on the crystallization of polypropylene subjected to an extensional flow. In this work, the flow around a single glass fiber upon uniaxial elongation of the melt is examined using X-ray scattering and diffraction techniques and compared to the response measured for the neat matrix. A comparison between a neat and compatibilized matrix is made given the strong influence of the addition of an adhesion modifier on the bulk crystallization kinetics of polypropylene. The flow is applied using an in-house-built filament stretching extensional rheometer, which, due to its midfilament control scheme, allows for in situ X-ray experiments. Combined small-angle X-ray scattering/wide-angle X-ray diffraction patterns are acquired during the flow and subsequent crystallization step. Postcrystallization area scans of the filament show that the introduction of a single glass fiber gives rise to the development of β-phase crystals, particularly in the area around the fiber ends, and in contrast to what is observed for the matrix materials alone, where solely α-phase is found. Surprisingly enough, the addition of a single fiber (0.00045 vol %) alters the crystallizing polymorph in almost the entire filament. However, the addition of the adhesion modifier hinders the formation of β-phase crystals around the fiber due to an acceleration of the bulk crystallization kinetics. Finite element simulations provide insight into the flow field around the fiber during stretching and demonstrate that the flow is no longer uniaxial extension, but dominated by shear, even though the volumetric amount of fiber as compared to the matrix is negligible. These findings explain the experimental observation of substantial β-phase formation after the introduction of a single fiber, while this is not observed in the matrix material. Worth noting, the formation of β-phase polypropylene depends not only on the presence and the strength of the flow but predominantly on the type of flow, i.e., shear as opposed to elongation

lipid use in hospitalized adults requiring parenteral nutrition

n/

Donor insulin use predicts beta‐cell function after islet transplantation

Insulin is routinely used to manage hyperglycaemia in organ donors and during the peri-transplant period in islet transplant recipients. However, it is unknown whether donor insulin use (DIU) predicts beta-cell dysfunction after islet transplantation. We reviewed data from the UK Transplant Registry and the UK Islet Transplant Consortium; all first-time transplants during 2008-2016 were included. Linear regression models determined associations between DIU, median and coefficient of variation (CV) peri-transplant glucose levels and 3-month islet graft function. In 91 islet cell transplant recipients, DIU was associated with lower islet function assessed by BETA-2 scores (β [SE] -3.5 [1.5], P = .02), higher 3-month post-transplant HbA1c levels (5.4 [2.6] mmol/mol, P = .04) and lower fasting C-peptide levels (−107.9 [46.1] pmol/l, P = .02). Glucose at 10 512 time points was recorded during the first 5 days peri-transplant: the median (IQR) daily glucose level was 7.9 (7.0-8.9) mmol/L and glucose CV was 28% (21%-35%). Neither median glucose levels nor glucose CV predicted outcomes post-transplantation. Data on DIU predicts beta-cell dysfunction 3 months after islet transplantation and could help improve donor selection and transplant outcomes

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial.

BACKGROUND: Biannual mass azithromycin administration to preschool children reduces all-cause mortality, but the mechanism for the effect is not understood. Azithromycin has activity against malaria parasites, and malaria is a leading cause of child mortality in the Sahel. The effect of biannual versus annual azithromycin distribution for trachoma control on serological response to merozoite surface protein 1 (MSP-119), a surrogate for malaria incidence, was evaluated among children in Niger. METHODS: Markers of malaria exposure were measured in two arms of a factorial randomized controlled trial designed to evaluate targeted biannual azithromycin distribution to children under 12 years of age compared to annual azithromycin to the entire community for trachoma control (N = 12 communities per arm). Communities were treated for 36 months (6 versus 3 distributions). Dried blood spots were collected at 36 months among children ages 1-5 years, and MSP-119 antibody levels were assessed using a bead-based multiplex assay to measure malaria seroprevalence. RESULTS: Antibody results were available for 991 children. MSP-119 seropositivity was 62.7% in the biannual distribution arm compared to 68.7% in the annual arm (prevalence ratio 0.91, 95% CI 0.83 to 1.00). Mean semi-quantitative antibody levels were lower in the biannual distribution arm compared to the annual arm (mean difference - 0.39, 95% CI - 0.05 to - 0.72). CONCLUSIONS: Targeted biannual azithromycin distribution was associated with lower malaria seroprevalence compared to that in a population that received annual distribution. Trial Registration Clinicaltrials.gov NCT00792922

High performance of the DNA methylation-based WID-qEC test for detecting uterine cancers independent of sampling modalities

Endometrial cancer (EC) is the most prevalent gynaecological cancer in high-income countries and its incidence is continuing to rise sharply. Simple and objective tools to reliably detect women with EC are urgently needed. We recently developed and validated the DNA methylation (DNAme)-based women's cancer risk identification—quantitative polymerase chain reaction test for endometrial cancer (WID-qEC) test that could address this need. Here, we demonstrate that the stability of the WID-qEC test remains consistent regardless of: (i) the cervicovaginal collection device and sample media used (Cervex brush and PreservCyt or FLOQSwab and eNAT), (ii) the collector of the specimen (gynaecologist- or patient-based), and (iii) the precise sampling site (cervical, cervicovaginal and vaginal). Furthermore, we demonstrate sample stability in eNAT medium for 7 days at room temperature, greatly facilitating the implementation of the test into diagnostic laboratory workflows. When applying FLOQSwabs (Copan) in combination with the eNAT (Copan) sample collection media, the sensitivity and specificity of the WID-qEC test to detect uterine (i.e., endometrial and cervical) cancers in gynaecologist-taken samples was 92.9% (95% confidence interval [CI] = 75.0%–98.8%) and 98.6% (95% CI = 91.7%–99.9%), respectively, whilst the sensitivity and specificity in patient collected self-samples was 75.0% (95% CI = 47.4%–91.7%) and 100.0% (95% CI = 93.9%–100.0%), respectively. Taken together these data confirm the robustness and clinical potential of the WID-qEC test

Phase locking the spin precession in a storage ring

This letter reports the successful use of feedback from a spin polarization measurement to the revolution frequency of a 0.97 GeV/$c$ bunched and polarized deuteron beam in the Cooler Synchrotron (COSY) storage ring in order to control both the precession rate ($\approx 121$ kHz) and the phase of the horizontal polarization component. Real time synchronization with a radio frequency (rf) solenoid made possible the rotation of the polarization out of the horizontal plane, yielding a demonstration of the feedback method to manipulate the polarization. In particular, the rotation rate shows a sinusoidal function of the horizontal polarization phase (relative to the rf solenoid), which was controlled to within a one standard deviation range of $\sigma = 0.21$ rad. The minimum possible adjustment was 3.7 mHz out of a revolution frequency of 753 kHz, which changes the precession rate by 26 mrad/s. Such a capability meets a requirement for the use of storage rings to look for an intrinsic electric dipole moment of charged particles

X-ray observations of highly obscured 9.7 micron sources: an efficient method for selecting Compton-thick AGN ?

Spitzer/IRS has revealed many sources with very deep Si features at 9.7micron (tau>1). We set out to investigate whether a strong Si absorption feature is a good indicator for the presence of a heavily obscured AGN. We compile X-ray spectroscopic observations available in the literature on the optically-thick,tau(9.7)>1 sources from the IRAS Seyfert sample. We find that the majority of the high-tau optically confirmed Seyferts (6/9) in this sample are probably CT. Thus we provide direct evidence for a connection between mid-IR optically-thick galaxies and CT AGN, with the success rate being close to 70% in the local Universe. This is at least comparable, if not better, than other rates obtained with photometric information in the mid to far-IR, or even mid-IR to Xray. However, this technique cannot provide complete CT AGN samples,ie there are many CT AGN which do not show significant Si absorption, with the most notable example being N1068. Having assessed the validity of the high 9.7micron technique locally, we attempt to construct a sample of candidate CT AGN at higher redshifts. We compile a sample of 7 high-tau sources in the GOODS and 5 in the Spitzer FLS. All these have been selected to have no PAH features EW(6.2)<0.3 in order to maximize the probability that they are AGN. 6 out of 7 sources in the GOODS have been detected in X-rays, while for the five FLS sources only X-ray flux upper limits are available. The high X-ray luminosities of the detected GOODS sources corroborates that these are AGN. For FLS, ancillary optical spectroscopy reveals hidden nuclei in two more sources. SED fitting can support the presence of an AGN in the vast majority of sources. We cannot derive useful X-ray spectroscopy constraints on whether these are CT. However, the low LX/L6 ratios, suggest that at least 4 out of the 6 detected sources in GOODS may be associated with CT AGN.Comment: 12 pages, to appear in A&A; version after language editin

Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study

Background: Treatment and control of malaria depends on artemisinin-based combination therapies (ACTs) and is challenged by drug resistance, but thus far resistance to artemisinins and partner drugs has primarily occurred in southeast Asia. The aim of this study was to characterise antimalarial drug susceptibility of Plasmodium falciparum isolates from Tororo and Busia districts in Uganda. Methods: In this prospective longitudinal study, P falciparum isolates were collected from patients aged 6 months or older presenting at the Tororo District Hospital (Tororo district, a site with relatively low malaria incidence) or Masafu General Hospital (Busia district, a high-incidence site) in eastern Uganda with clinical symptoms of malaria, a positive Giemsa-stained blood film for P falciparum, and no signs of severe disease. Ex-vivo susceptibilities to ten antimalarial drugs were measured using a 72-h microplate growth inhibition assay with SYBR Green detection. Relevant P falciparum genetic polymorphisms were characterised by molecular methods. We compared results with those from earlier studies in this region and searched for associations between drug susceptibility and parasite genotypes. Findings: From June 10, 2016, to July 29, 2019, 361 P falciparum isolates were collected in the Busia district and 79 in the Tororo district from 440 participants. Of 440 total isolates, 392 (89%) successfully grew in culture and showed excellent drug susceptibility for chloroquine (median half-maximal inhibitory concentration [IC50] 20·0 nM [IQR 12·0-26·0]), monodesethylamodiaquine (7·1 nM [4·3-8·9]), pyronaridine (1·1 nM [0·7-2·3]), piperaquine (5·6 nM [3·3-8·6]), ferroquine (1·8 nM [1·5-3·3]), AQ-13 (24·0 nM [17·0-32·0]), lumefantrine (5·1 nM [3·2-7·7]), mefloquine (9·5 nM [6·6-13·0]), dihydroartemisinin (1·5 nM [1·0-2·0]), and atovaquone (0·3 nM [0·2-0·4]). Compared with results from our study in 2010-13, significant improvements in susceptibility were seen for chloroquine (median IC50 288·0 nM [IQR 122·0-607·0]; p\u3c0·0001), monodesethylamodiaquine (76·0 nM [44·0-137]; p\u3c0·0001), and piperaquine (21·0 nM [7·6-43·0]; p\u3c0·0001), a small but significant decrease in susceptibility was seen for lumefantrine (3·0 nM [1·1-7·6]; p\u3c0·0001), and no change in susceptibility was seen with dihydroartemisinin (1·3 nM [0·8-2·5]; p=0·64). Chloroquine resistance (IC50\u3e100 nM) was more common in isolates from the Tororo district (11 [15%] of 71), compared with those from the Busia district (12 [4%] of 320; p=0·0017). We showed significant increases between 2010-12 and 2016-19 in the prevalences of wild-type P falciparum multidrug resistance protein 1 (PfMDR1) Asn86Tyr from 60% (391 of 653) to 99% (418 of 422; p\u3c0·0001), PfMDR1 Asp1246Tyr from 60% (390 of 650) to 90% (371 of 419; p\u3c0·0001), and P falciparum chloroquine resistance transporter (PfCRT) Lys76Thr from 7% (44 of 675) to 87% (364 of 417; p\u3c0·0001). Interpretation: Our results show marked changes in P falciparum drug susceptibility phenotypes and genotypes in Uganda during the past decade. These results suggest that additional changes will be seen over time and continued surveillance of susceptibility to key ACT components is warranted. Funding: National Institutes of Health and Medicines for Malaria Venture